Skip to main content

Table 2 Marginal Annual Effects of Colorectal Cancer Testing Overall and by Modality in 16 Medicaid ACOs, 2011–2014 Compared to 2010, percentage point (p-value)

From: Does a transition to accountable care in Medicaid shift the modality of colorectal cancer testing?

  CRC Screening Modality
Year effect relative to 2010 Any CRC screening Colonoscopy FOBT/FIT Flexible sigmoidoscopy
2011 0.007 (< 0.001) 0.005 (< 0.001) 0.002 (< 0.001) < 0.001 (< 0.001)
2012 0.001 (0.333) 0.001 (0.022) 0.000 (0.691) < 0.001 (< 0.001)
2013 0.001 (0.104) −0.001 (0.186) 0.002 (< 0.001) −0.001 (< 0.001)
2014 0.014 (< 0.001) 0.006 (< 0.001) 0.007 (< 0.001) < 0.001 (< 0.001)
  1. Note: Each column represents a separate regression model. These coefficients represent the annual marginal change in the predicted probability of the outcome relative to the baseline year (2010). Each model also controls for age, gender, race/ethnicity, chronic disease risk, urbanicity, PCP visit during the calendar year, CCO assignment, and calendar quarter. Results are interpreted as percentage point changes compared to a 2010 baseline